News

Helius Medical Technologies Showcases PoNS Therapy Study Results

Helius Medical Technologies Showcases PoNS Therapy Study Results

Exciting Developments in Gait Therapy for MS Patients

Helius Medical Technologies, Inc. (NASDAQ: HSDT), a pioneering neurotech company, is thrilled to unveil important findings concerning its Portable Neuromodulation Stimulator (PoNS). This innovative device addresses balance and gait challenges faced by those with multiple sclerosis (MS). The revelations will be presented at the Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, taking place between May 28 and May 31 at the Phoenix Convention Center.

Unveiling Findings from the PoNS Therapeutic Experience Program

Dr. Deborah Backus, the Vice President of Research and Innovation at a leading rehabilitation center, will showcase the study results during a platform presentation on May 29. This marks a significant moment as it’s the first presentation of the full study results, which highlight the effectiveness of PoNS Therapy in enhancing the mobility of MS patients.

The Importance of Adherence to PoNS Therapy

In the innovative PoNSTEP study, data revealed a crucial connection between adherence to the PoNS regimen and improvement in mobility. Dr. Backus indicated that the data shows not just anecdotal benefits; there’s a statistically significant correlation between sticking to the PoNS treatment plan and improvements in walking ability. This is particularly impactful for individuals with MS who often see few options for effective treatment of their gait deficits.

Study Design and Patient Outcomes

The design of the PoNSTEP study engaged participants through a structured three-phase approach. Initially, patients underwent two weeks of in-clinic therapy, followed by 12 weeks of therapy that integrated both clinic visits and home use. The study concluded with a six-month follow-up to assess the longevity of the improvements achieved.

A key finding from PoNSTEP is the positive effect of commitment to the therapy. Participants who adhered to the therapy—utilizing the device for the recommended 100–120 minutes a day—saw substantial improvements in their Dynamic Gait Index (DGI) scores, indicating better walking function and balance. The most committed individuals achieved gains exceeding six points in their scores, demonstrating a direct relationship between adherence and therapy outcomes.

Durability of Treatment Effects

The long-term benefits of PoNS Therapy were made evident through follow-up evaluations. Over 95% of participants maintained their improvement levels six months post-treatment. This highlights the treatment's potential to not only provide immediate benefits but also sustainable improvements in gait and balance for MS patients.

Significance in Neuromodulation and Rehabilitation

Dr. Favit-Van Pelt, the Chief Medical Officer, emphasized the importance of these findings for the MS community. The study adds to the growing body of evidence that showcases the capabilities of neuromodulation therapies in rehabilitating neural networks and enhancing neuroplasticity, which are critical in treating conditions like MS. With the challenges many patients face regarding mobility, the ability offered by PoNS therapy to drive measurable improvements comes as a beacon of hope.

This therapy is gaining traction, with insurance providers, including the U.S. Department of Veterans Affairs and the Department of Defense, beginning to reimburse for PoNS treatment, marking an essential step toward broader accessibility for affected individuals.

About Helius Medical Technologies

Helius Medical Technologies is leading the charge in the neurotech industry with their specialized oral device designed to stimulate the brain’s natural healing processes. Their flagship product, the Portable Neuromodulation Stimulator, plays a pivotal role in aiding those suffering from neurologic deficits. The company remains dedicated to advancing treatment options that significantly improve patients' quality of life regarding their neurological needs.

Frequently Asked Questions

What is PoNS therapy?

PoNS therapy utilizes a non-implantable device that provides neurostimulation to improve balance and gait in patients with conditions like multiple sclerosis.

How was the PoNSTEP study structured?

The PoNSTEP study involved three phases: two weeks of in-clinic therapy, 12 weeks of combined clinic and home use, followed by a six-month follow-up.

What were the key findings from the PoNSTEP study?

The study found a significant relationship between adherence to PoNS therapy and improved gait function, with lasting effects noted six months post-treatment.

Who presented the study results at the CMSC Annual Meeting?

Dr. Deborah Backus will present the study findings, highlighting their impact on enhancing mobility for MS patients.

What is the significance of this study for MS patients?

This study confirms the therapeutic potential of PoNS Therapy, providing a viable treatment choice for improving mobility in individuals with MS.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cinmoore's Smart Camera: A Game Changer for Car Security

Updated Category News Views 96

Pioneering Car Security with Cinmoore's Smart Camera Ever left your car in the parking lot, heart pounding, wondering if it's safe while you run errands? Well, Cinmoore might just quell that parking paranoia with their new gizmo, the Smart Parking Camera DC1U. This device isn't just some fancily-packaged disappointment—it promises some serious peace of mind for those...

Continue Reading
A Teen's Opera Encounter Inspires Decades of Passion

Updated Category News Views 94

Unraveling a Lifelong Opera Obsession Back in the dog-eared days of 1970, a teenager waltzed into the Metropolitan Opera and stumbled onto a passion that'd pulse alongside him for over half a century. Now, David E. Lapin rolls out his personal chronicle, 'A Sound Obsession: Fifty-Five Years of Opera at the Met.' Folks, we’re diving into a cultural tapestry that’s...

Continue Reading
Shareholder Alert: Investigation Looms Over GDYN

Updated Category News Views 55

Grid Dynamics Under Legal Scrutiny There’s nothing quite like waking up to find your pick embroiled in an investigation. Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) is on the radar, with law firm Levi & Korsinsky diving headfirst into potential infractions of fiduciary duties by some of the company’s top brass. The Lowdown on the Investigation This whole circus was...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 122

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 142

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading
Surgical Tooth Extraction: When It’s Necessary

Updated Category News Views 98

Unpacking the Complexities of Tooth Extraction Ever wonder why some tooth extractions are a stroll in the park while others dive straight into surgical territory? It's all about positioning, condition, and what's lurking underneath. Thanks to Dr. Yadira Cardona-Rohena of Hamilton Mill Oral & Facial Surgery, we’ve got the lowdown. The Need for Skilled Surgical Techniques...

Continue Reading
Exploring Why Dead Outlets Stay Dead: Expert Insights

Updated Category News Views 86

The Mystery of Non-Responsive Outlets Ever found an electrical outlet refusing to cooperate when you need it most? Well, I know the frustration all too well. You'd think if the breaker ain't blown, the outlet should work like a charm. But dive into the guts of the story, and you find a series of surprises waiting to trip us up. Common Culprits: Tripped GFCIs and Loose...

Continue Reading
Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 25

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
Kinross Gold Fraud Lawsuit: What Shareholders Need to Know

Updated Category News Views 58

Kinross Gold's Legal Quagmire There's a fresh storm brewing for Kinross Gold Corporation (NYSE: KGC), and it ain't the kind investors enjoy riding. You see, the company is up to its neck in a class action lawsuit, courtesy of Schall, Brown & Schwartz LLP—a big-name shareholder rights litigation outfit. The gripe? Alleged securities fraud, violating §§10(b) and 20(a)...

Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 73

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Trump's Tariff Threats Spark Global Market Reactions

Updated Category News Views 163

Market Reactions to Tariff Developments As global markets navigate uncertain waters today, optimism and anxiety intertwine. The US dollar has taken a slight step higher, while gold has seen a dip, all stemming from ongoing trade tensions and recent tariff announcements by President Trump. With negotiations that are seen as promising but fraught with complexities, the...

Continue Reading
Sutro Biopharma's Upcoming Presentation at J.P. Morgan Event

Updated Category News Views 228

Sutro Biopharma's Upcoming Conference Presentation Sutro Biopharma, Inc. (NASDAQ: STRO), a trailblazer in oncology therapies based in South San Francisco, has some exciting news. The company announced that its Chief Executive Officer, Bill Newell, will be presenting at the prestigious J.P. Morgan Healthcare Conference. This annual event is a pivotal opportunity for...

Continue Reading
Nightly Launches Ambitious $25 Million Experience Initiative

Updated Category News Views 302

Nightly Introduces a $25 Million Initiative In a bold move to reshape the live entertainment landscape, Nightly has announced a substantial $25 million initiative aimed at expanding its dynamic experiences across the nation. Originating from Dallas, Nightly has quickly evolved into a cultural movement that seeks to redefine nightlife specifically for Gen Z audiences. This...

Continue Reading
Tecan Announces 2024 Results, Focuses on Growth and Innovation

Updated Category News Views 609

Tecan Reports 2024 Financial Results Amid Market Challenges Overview of Financial Highlights Tecan has unveiled its financial results for 2024, showcasing a robust commitment to enhancing operational resilience in a challenging market environment. Sales figures totaled CHF 934.3 million, marking a decline from the previous year's CHF 1,074.4 million. This 13.0% drop in...

Continue Reading
Auddia, Inc. (AUUD) Merger: Shareholder Alert and Investigation Insights

Updated Category News Views 227

Auddia, Inc. (NASDAQ: AUUD) is under the microscope after news broke about its proposed merger with McCarthy Finney, Inc., which sent shockwaves through trader desks and shareholder circles alike. The date was February 18, 2026, when class action attorney Juan Monteverde announced an investigation into the deal that’s left many scratching their heads about whether this...

Continue Reading